Integrated BioPharma, Inc. (INBP)
0.182
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Integrated BioPharma Gross Profit Margin (Quarterly) : 0.29% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.29% |
| March 31, 2026 | -2.73% |
| December 31, 2025 | 0.26% |
| September 30, 2025 | 8.03% |
| June 30, 2025 | 10.36% |
| March 31, 2025 | 11.12% |
| December 31, 2024 | 9.28% |
| September 30, 2024 | 10.07% |
| June 30, 2024 | 9.39% |
| March 31, 2024 | 9.49% |
| December 31, 2023 | 4.52% |
| September 30, 2023 | 6.44% |
| June 30, 2023 | 7.59% |
| March 31, 2023 | 7.70% |
| December 31, 2022 | 8.73% |
| September 30, 2022 | 8.09% |
| June 30, 2022 | 10.52% |
| March 31, 2022 | 12.68% |
| December 31, 2021 | 11.99% |
| September 30, 2021 | 11.17% |
| June 30, 2021 | 12.83% |
| March 31, 2021 | 15.59% |
| December 31, 2020 | 15.25% |
| September 30, 2020 | 15.64% |
| June 30, 2020 | 10.17% |
| Date | Value |
|---|---|
| March 31, 2020 | 13.59% |
| December 31, 2019 | 14.27% |
| September 30, 2019 | 12.27% |
| June 30, 2019 | 11.62% |
| March 31, 2019 | 14.86% |
| December 31, 2018 | 11.08% |
| September 30, 2018 | 11.83% |
| June 30, 2018 | 11.67% |
| March 31, 2018 | 13.89% |
| December 31, 2017 | 9.70% |
| September 30, 2017 | 10.29% |
| June 30, 2017 | 14.95% |
| March 31, 2017 | 12.33% |
| December 31, 2016 | 11.68% |
| September 30, 2016 | 16.77% |
| June 30, 2016 | 16.39% |
| March 31, 2016 | 11.84% |
| December 31, 2015 | 9.13% |
| September 30, 2015 | 13.59% |
| June 30, 2015 | 10.10% |
| March 31, 2015 | 8.94% |
| December 31, 2014 | 11.87% |
| September 30, 2014 | 14.76% |
| June 30, 2014 | 12.91% |
| March 31, 2014 | 9.21% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Medifast, Inc. | 69.90% |
| Skinvisible, Inc. | 0.00% |
| Nevis Brands, Inc. | -- |
| Functional Brands, Inc. | 59.89% |
| Cyanotech Corp. | 42.38% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -14.62% |
| Return on Assets | -11.28% |
| Return on Invested Capital | -13.41% |
| Profit Margin (Quarterly) | -13.94% |
| Operating Margin (Quarterly) | -8.87% |
| Return on Net Operating Assets | -17.12% |